Astrana Health, Inc.
General ticker "ASTH" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.3B (TTM average)
Astrana Health, Inc. follows the US Stock Market performance with the rate: 43.3%.
Estimated limits based on current volatility of 2.7%: low 34.92$, high 36.87$
Factors to consider:
- Earnings expected soon, date: 2026-08-06 amc
- Total employees count: 3000 (+57.9%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Acquisition/divestiture risks, Capital raising, Regulatory and compliance, Economic downturns and volatility, Cybersecurity threats
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [19.90$, 35.44$]
- 2026-12-31 to 2027-12-31 estimated range: [19.48$, 34.81$]
Financial Metrics affecting the ASTH estimates:
- Positive: with PPE of 28.2 at the end of fiscal year the price was neutral
- Positive: -4.17 < Operating profit margin, % of 2.47
- Positive: 6.73 < Operating cash flow per share per price, % of 9.40
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.54
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -9.07 < Industry operating profit margin (median), % of -0.34
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
- Positive: 19.10 < Shareholder equity ratio, % of 35.12 <= 42.34
Short-term ASTH quotes
Long-term ASTH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,386.66MM | $2,034.54MM | $3,181.77MM |
| Operating Expenses | $1,302.05MM | $1,945.19MM | $3,103.24MM |
| Operating Income | $84.61MM | $89.35MM | $78.53MM |
| Non-Operating Income | $5.22MM | $-8.53MM | $-38.92MM |
| Interest Expense | $16.10MM | $33.10MM | $49.93MM |
| Income(Loss) | $89.84MM | $80.82MM | $39.61MM |
| Taxes | $31.99MM | $30.89MM | $15.53MM |
| Net Income(Loss)* | $60.72MM | $43.15MM | $22.49MM |
| Stockholders Equity | $614.22MM | $712.72MM | $779.29MM |
| Assets | $933.36MM | $1,354.89MM | $2,218.66MM |
| Operating Cash Flow | $68.23MM | $52.20MM | $114.60MM |
| Capital expenditure | $28.53MM | $8.03MM | $10.11MM |
| Investing Cash Flow | $-65.52MM | $-192.40MM | $-539.00MM |
| Financing Cash Flow | $3.42MM | $135.15MM | $569.35MM |
| Earnings Per Share** | $1.30 | $0.90 | $0.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.